Significant protection against respiratory syncytial virus (RSV) infection was induced in mice vaccinated intramuscularly (i.m.) with DNA encoding the F or G protein of RSV. The amounts of IgG1 of IgG2a antibodies in mice immunized with DNA-G alone were similar. However, the antibody response in mice co-immunized with DNA-G and DNA encoding IL-4 (DNA-IL-4) was strongly biased towards IgG1. In contrast, the antibody response in mice co-immunized with DNA-G and DNA-IL-2, -IL-12 or-IFN-γ was biased towards IgG2a. Mice vaccinated with DNA-F either alone or in combination with DNA encoding cytokines developed a predominant RSV-specific IgG2a response, which was most pronounced in mice co-immunized with DNA-F and DNA-IL-12 or -IFN-γ. Vaccinated mice developed only a slightly enhanced pulmonary inflammatory response following RSV challenge. More significantly, and in contrast to mice scarified with recombinant vaccinia virus expressing the G protein, mice vaccinated i.m. with DNA-G did not develop pulmonary eosinophilia, even when the immune response was biased towards a Th2 response by co-administration of DNA-IL-4.
AlwanW. H.,
OpenshawP. J. M.1993; Distinct patterns of T- and B-cell immunity to respiratory syncytial virus induced by individual viral proteins. Vaccine 11:431–437
AlwanW. H.,
RecordF. M.,
OpenshawP. J.1993; Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. Journal of Immunology 150:5211–5218
BembridgeG. P.,
Garcia-BeatoR.,
LopezJ. A.,
MeleroJ. A.,
TaylorG.1998 a; Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein. Journal of Immunology 161:2473–2480
BembridgeG. P.,
LopezJ. A.,
CookR.,
MeleroJ. A.,
TaylorG.1998 b; Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon. Journal of Virology 72:4080–4087
BembridgeG. P.,
LopezJ. A.,
BustosR.,
MeleroJ. A.,
CookR.,
MasonH.,
TaylorG.1999; Priming with a secreted form of the fusion protein of respiratory syncytial virus (RSV) promotes interleukin-4 (IL-4) and IL-5 production but not pulmonary eosinophilia following RSV challenge. Journal of Virology 73:10086–10094
ConnorsM.,
GieseN. A.,
KulkarniA. B.,
FirestoneC. Y.,
MorseH. C.III.,
MurphyB. R.1994; Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. Journal of Virology 68:5321–5325
FeltquateD. M.,
HeaneyS.,
WebsterR. G.,
RobinsonH. L.1997; Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. Journal of Immunology 158:2278–2284
GrahamB. S.,
HendersonG. S.,
TangY. W.,
LuX.,
NeuzilK. M.,
ColleyD. G.1993; Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. Journal of Immunology 151:2032–2040
HussellT.,
KhanU.,
OpenshawP.1997; IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness. Journal of Immunology 159:328–334
LiX.,
SambharaS.,
LiC. X.,
EwasyshynM.,
ParringtonM.,
CateriniJ.,
JamesO.,
CatesG.,
DuR.-P.,
KleinM.1998; Protection against respiratory syncytial virus infection by DNA immunization. Journal of Experimental Medicine 188:681–688
OpenshawP. J.,
ClarkeS. L.,
RecordF. M.1992; Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G. International Immunology 4:493–500
PertmerT. M.,
RobertsT. R.,
HaynesJ. R.1996; Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. Journal of Virology 70:6119–6125
SchrijverR. S.,
LangedijkJ. P. M.,
KeilG. M.,
MiddelW. G. J.,
Maris-VeldhuisM.,
van OirschotJ. T.,
RijsewijkF. A. M.1997; Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine 15:1908–1916
StottE. J.,
TaylorG.,
BallL. A.,
AndersonK.,
YoungK. K.-Y.,
KingA. M. Q.,
WertzG. W.1987; Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. Journal of Virology 61:3855–3861
TangY. W.,
GrahamB. S.1995; Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity. Journal of Infectious Diseases 172:734–738
TrippR. A.,
MooreD.,
JonesL.,
SullenderW.,
WinterJ.,
AndersonL. J.1999; Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. Journal of Virology 73:7099–7107
XiangZ.,
ErtlH. C.1995; Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129–135